4.3 Article

Recurrent Miscarriage Clinics

Journal

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ogc.2013.10.010

Keywords

Recurrent miscarriage; Recurrent miscarriage clinic; Quality of care; Guideline adherence; Patient preferences

Ask authors/readers for more resources

A recurrent miscarriage clinic offers specialist investigation and treatment of women with recurrent first- and second-trimester miscarriages. Consultant-led clinics provide a dedicated and focused service to couples who have experienced at least two prior miscarriages. The best treatment strategy for couples with recurrent miscarriage is to discuss a treatment plan for a future pregnancy. Evidence-based up-to-date guidelines are required to reduce ineffective management of recurrent miscarriage couples, including overdiagnostics and underdiagnostics. Scientific research is necessary to study the effectiveness of new interventions, to study patient preferences, and to evaluate health care and costs or other outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples

Ivy van Dijke, Phillis Lakeman, Inge B. Mathijssen, Mariette Goddijn, Martina C. Cornel, Lidewij Henneman

Summary: For couples at risk of a specific genetic disorder, the availability of new genetic technologies such as NIPD, GGE, and SGE may impact their reproductive decision-making process. Safety, burden, and moral considerations play crucial roles in their preferences for different options. Understanding these perspectives can aid counselors in guiding couples through increasingly complex reproductive choices.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Obstetrics & Gynecology

The long-term costs and effects of tubal flushing with oil-based versus water-based contrast during hysterosalpingography

Nienke van Welie, Clarabelle T. Pham, Joukje van Rijswijk, Kim Dreyer, Harold R. Verhoeve, Annemieke Hoek, Jan Peter de Bruin, Annemiek W. Nap, Machiel H. A. van Hooff, Mariette Goddijn, Angelo B. Hooker, Anna P. Gijsen, Maaike A. F. Traas, Jesper M. J. Smeenk, Alexander Sluijmer, Marieke J. Lambers, Gijsbertus A. van Unnik, Cornelia H. de Koning, Alexander Mozes, Catharina C. M. Timmerman, Cornelis B. Lambalk, Jonathan D. Karnon, Velja Mijatovic, Ben Willem J. Mol

Summary: Research comparing oil-based contrast versus water-based contrast in hysterosalpingography for infertile women found that the oil-based contrast resulted in a 5% increase in ongoing pregnancy rate and a 7.5% increase in live birth rate over a 5-year period, with similar costs to water-based contrast.

REPRODUCTIVE BIOMEDICINE ONLINE (2021)

Article Hematology

Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?

Eva N. Hamulyak, Luuk J. J. Scheres, Mariette Goddijn, Saskia Middeldorp

Summary: Aspirin and heparin are commonly used to reduce the risk of recurrent pregnancy loss in women with antiphospholipid syndrome. Evidence suggests that heparin plus aspirin may improve live birth rates in these women, but the certainty of this evidence is low.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Obstetrics & Gynecology

Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial

J. F. W. Rikken, C. R. Kowalik, M. H. Emanuel, M. Y. Bongers, T. Spinder, F. W. Jansen, A. G. M. G. J. Mulders, R. Padmehr, T. J. Clark, H. A. van Vliet, M. D. Stephenson, F. van der Veen, B. W. J. Mol, M. van Wely, M. Goddijn

Summary: According to an international study, hysteroscopic septum resection does not improve the chance of live birth in women with a septate uterus. Despite limitations, the study provides high-level evidence on this issue.

HUMAN REPRODUCTION (2021)

Review Medicine, General & Internal

Recurrent miscarriage: evidence to accelerate action

Arri Coomarasamy, Rima K. Dhillon-Smith, Argyro Papadopoulou, Maya Al-Memar, Jane Brewin, Vikki M. Abrahams, Abha Maheshwari, Ole B. Christiansen, Mary D. Stephenson, Mariette Goddijn, Olufemi T. Oladapo, Chandrika N. Wijeyaratne, Debra Bick, Hassan Shehata, Rachel Small, Phillip R. Bennett, Lesley Regan, Raj Rai, Tom Bourne, Rajinder Kaur, Oonagh Pickering, Jan J. Brosens, Adam J. Devall, Ioannis D. Gallos, Siobhan Quenby

Summary: Women who have experienced recurrent miscarriages often have uncertainties about the causes, risks, necessary investigations, and treatments. This paper suggests individualized care and a minimum set of investigations and treatments for couples with a history of recurrent miscarriage, while emphasizing screening and care for mental health issues and future obstetric risks. Health care services may consider a graded care model to provide appropriate care for these couples.

LANCET (2021)

Review Medicine, General & Internal

Sporadic miscarriage: evidence to provide effective care

Arri Coomarasamy, Ioannis D. Gallos, Argyro Papadopoulou, Rima K. Dhillon-Smith, Maya Al-Memar, Jane Brewin, Ole B. Christiansen, Mary D. Stephenson, Olufemi T. Oladapo, Chandrika N. Wijeyaratne, Rachel Small, Phillip R. Bennett, Lesley Regan, Mariette Goddijn, Adam J. Devall, Tom Bourne, Jan J. Brosens, Siobhan Quenby

Summary: The physical and psychological effects of miscarriage are often underestimated, with diagnostic challenges leading to delays in care and increased anxiety. Recommendations for comprehensive miscarriage care include reporting annual aggregate data, providing effective ultrasound services, and investing in training for healthcare providers.

LANCET (2021)

Letter Obstetrics & Gynecology

Antithrombotic therapy for live birth in women with recurrent pregnancy loss: do not confound available high-level evidence

Luuk J. J. Scheres, Saskia Middeldorp, Mariette Goddijn

HUMAN REPRODUCTION (2022)

Article Obstetrics & Gynecology

ESHRE guideline: recurrent pregnancy loss: an update in 2022

Ruth Bender Atik, Ole Bjarne Christiansen, Janine Elson, Astrid Marie Kolte, Sheena Lewis, Saskia Middeldorp, Saria Mcheik, Braulio Peramo, Siobhan Quenby, Henriette Svarre Nielsen, Marie-Louise van der Hoorn, Nathalie Vermeulen, Mariette Goddijn

Summary: The guideline on the management of women with recurrent pregnancy loss (RPL) has been updated based on the best available evidence from 2017 to 2022. The updated guideline includes 11 updated recommendations and one new recommendation on adenomyosis investigation.

HUMAN REPRODUCTION OPEN (2022)

Article Obstetrics & Gynecology

The needs of subfertile couples continuing to attempt natural conception: in-depth interviews

Felicia Dreischor, Ellen T. M. Laan, Fleur Peeters, Karen Peeraer, Cornelis B. Lambalk, Mariette Goddijn, Inge M. Custers, Eline A. F. Dancet

Summary: Couples hope for fertility clinic staff to incorporate expectant management into the clinic trajectory, interact with both partners, and provide advice on common peer experiences, lifestyle management, distress, and sexual challenges.

HUMAN REPRODUCTION OPEN (2022)

Article Obstetrics & Gynecology

The ethics of preconception expanded carrier screening in patients seeking assisted reproduction

Guido de Wert, Sanne van der Hout, Mariette Goddijn, Rita Vassena, Lucy Frith, Nathalie Vermeulen, Ursula Eichenlaub-Ritter

Summary: Expanded carrier screening is being increasingly offered to patients seeking assisted reproduction, raising ethical concerns regarding the professional responsibilities and potential benefits and harms of such screenings. Some European fertility clinics already provide preconception ECS, prompting a need for ethical guidance in this area. Patients undergoing assisted reproduction may have a particular interest in preconception ECS due to the burdens they already face, leading to unique ethical questions that require consideration.

HUMAN REPRODUCTION OPEN (2021)

Article Obstetrics & Gynecology

The experiences of women with breast cancer who undergo fertility preservation

T. Dahhan, F. van der Veen, A. M. E. Bos, M. Goddijn, E. A. F. Dancet

Summary: Through in-depth interviews, the study revealed that women newly diagnosed with breast cancer experienced the burden of fertility preservation, adopting a new identity as fertility patients, and coping with breast cancer through fertility preservation.

HUMAN REPRODUCTION OPEN (2021)

Correction Obstetrics & Gynecology

The ethics of preconception expanded carrier screening in patients seeking assisted reproduction (vol 2021, hoaa063, 2021)

Guido de Wert, Sanne van der Hout, Mariette Goddijn, Rita Vassena, Lucy Frith, Nathalie Vermeulen, Ursula Eichenlaub-Ritter

HUMAN REPRODUCTION OPEN (2021)

Article Oncology

Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology

Mandy Spaan, Alexandra W. Van den Belt-Dusebout, Cornelis B. Lambalk, Hester H. van Boven, Roel Schats, Marian Kortman, Frank J. M. Broekmans, Joop S. E. Laven, Evert J. P. van Santbrink, Didi D. M. Braat, Lucette A. J. van der Westerlaken, Ben J. Cohlen, Astrid E. P. Cantineau, Jesper M. J. Smeenk, Minouche M. van Rumste, Mariette Goddijn, Ron J. T. van Golde, Paul A. M. Meeuwissen, Carl J. C. M. Hamilton, Gabriele M. Ouwens, Miranda A. Gerritsma, Michael Schaapveld, Curt W. Burger, Flora E. van Leeuwen

Summary: The use of assisted reproductive technology may be associated with an increased risk of ovarian cancer, although this may be more related to nulliparity rather than the treatment itself. On the other hand, there is a significantly increased risk of borderline ovarian tumors following assisted reproductive technology, but no dose-response relationship was observed.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Obstetrics & Gynecology

Increased obstetric and neonatal risks in artificial cycles for frozen embryo transfers

Tjitske R. Zaat, Anna J. Brinks, Jan-Peter De Bruin, Mariette Goddijn, Frank J. M. Broekmans, Ben J. Cohlen, Nick S. Macklon, Madelon van Wely, Eva R. Groenewoud, Femke Mol

Summary: The study compared obstetric and neonatal risks for women undergoing frozen-thawed embryo transfer during a modified natural cycle versus an artificial cycle. Results showed that women who conceived via modified natural cycle had a decreased risk of hypertensive disorders of pregnancy compared to those using artificial cycle. Other outcomes did not show significant differences between the two methods.

REPRODUCTIVE BIOMEDICINE ONLINE (2021)

Review Medicine, General & Internal

Fresh versus frozen embryo transfers in assisted reproduction (Review)

Tjitske Zaat, Miriam Zagers, Femke Mol, Mariette Goddijn, Madelon van Wely, Sebastiaan Mastenbroek

Summary: Based on the study, the 'freeze all' strategy may not have a significant difference compared to the conventional IVF/ICSI strategy in terms of cumulative live birth rate and ongoing pregnancy rate, but may have a lower risk of ovarian hyperstimulation syndrome. However, other risks such as maternal hypertensive disorders of pregnancy and having a large-for-gestational-age baby may increase with the 'freeze all' strategy.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

No Data Available